CELLINI, Luigina
 Distribuzione geografica
Continente #
NA - Nord America 12.960
EU - Europa 8.408
AS - Asia 7.567
SA - Sud America 913
Continente sconosciuto - Info sul continente non disponibili 562
AF - Africa 124
OC - Oceania 13
Totale 30.547
Nazione #
US - Stati Uniti d'America 12.538
SG - Singapore 2.843
CN - Cina 2.141
IT - Italia 1.970
UA - Ucraina 1.138
IE - Irlanda 1.001
TR - Turchia 858
RU - Federazione Russa 818
SE - Svezia 806
BR - Brasile 727
GB - Regno Unito 701
FR - Francia 694
VN - Vietnam 645
DE - Germania 519
IN - India 496
FI - Finlandia 260
CA - Canada 191
PL - Polonia 176
BD - Bangladesh 128
HK - Hong Kong 96
AR - Argentina 69
MX - Messico 66
NL - Olanda 61
CZ - Repubblica Ceca 52
IQ - Iraq 46
JP - Giappone 43
IR - Iran 37
RO - Romania 35
ES - Italia 34
IL - Israele 34
EC - Ecuador 32
ID - Indonesia 32
BE - Belgio 29
KR - Corea 28
PH - Filippine 28
ZA - Sudafrica 28
CO - Colombia 27
CR - Costa Rica 27
LT - Lituania 24
VE - Venezuela 20
GT - Guatemala 19
TT - Trinidad e Tobago 19
HN - Honduras 18
JM - Giamaica 17
SC - Seychelles 17
CW - ???statistics.table.value.countryCode.CW??? 16
PR - Porto Rico 16
EU - Europa 15
GP - Guadalupe 15
AE - Emirati Arabi Uniti 14
PK - Pakistan 14
PY - Paraguay 14
AT - Austria 13
AU - Australia 13
CH - Svizzera 13
GR - Grecia 13
SV - El Salvador 12
EE - Estonia 11
SA - Arabia Saudita 11
CL - Cile 10
EG - Egitto 10
DZ - Algeria 9
KE - Kenya 9
MY - Malesia 9
NI - Nicaragua 9
JO - Giordania 8
MA - Marocco 8
PT - Portogallo 8
TN - Tunisia 8
ET - Etiopia 7
UZ - Uzbekistan 7
BG - Bulgaria 6
NG - Nigeria 6
AZ - Azerbaigian 5
KZ - Kazakistan 5
NP - Nepal 5
PS - Palestinian Territory 5
UY - Uruguay 5
AL - Albania 4
BH - Bahrain 4
BO - Bolivia 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
OM - Oman 4
PE - Perù 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BB - Barbados 3
GE - Georgia 3
KG - Kirghizistan 3
LY - Libia 3
MD - Moldavia 3
NO - Norvegia 3
SL - Sierra Leone 3
CG - Congo 2
GD - Grenada 2
HR - Croazia 2
KH - Cambogia 2
LB - Libano 2
Totale 29.988
Città #
Singapore 2.032
San Jose 1.324
Jacksonville 1.299
Chandler 1.004
Dublin 952
Ashburn 652
Dallas 541
Beijing 505
Council Bluffs 497
Princeton 487
Southend 456
Izmir 443
Nanjing 405
Dearborn 382
Santa Clara 291
Los Angeles 279
Chieti 269
Wilmington 247
New York 239
Ho Chi Minh City 229
Cambridge 220
Buffalo 182
The Dalles 180
Ann Arbor 169
Tongling 165
Hanoi 155
Woodbridge 131
Nanchang 130
Altamura 122
Kraków 122
Munich 101
Moscow 100
Hong Kong 89
Pescara 79
Hebei 75
Rome 75
Milan 74
North Bergen 74
São Paulo 74
Kunming 72
Boardman 66
Tianjin 62
Shenyang 52
Orem 51
Grevenbroich 50
Montreal 49
Toronto 45
Chennai 44
Houston 44
Phoenix 43
Brooklyn 42
Atlanta 39
Redondo Beach 39
San Mateo 39
Washington 39
Denver 38
Da Nang 37
Tokyo 37
Warsaw 37
Columbus 36
Jiaxing 36
Hefei 35
London 34
Naples 34
Augusta 33
Chicago 33
Stockholm 32
Brno 31
Ardabil 30
Changsha 30
Hangzhou 30
Mumbai 30
Ancona 29
Leawood 27
San Francisco 27
Helsinki 26
Amsterdam 25
Brussels 25
Norwalk 25
Rio de Janeiro 25
Bari 24
Seoul 24
Jinan 23
Kocaeli 23
Lanzhou 23
Bologna 22
Kimball 22
Vasto 22
Haiphong 21
Orange 21
San José 21
Turku 21
Baghdad 20
Irving 20
Olomouc 20
Boston 19
Changchun 19
Frankfurt am Main 19
Las Vegas 19
Mexico City 19
Totale 16.830
Nome #
Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains 255
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 254
Differenziamento reale e differenziamento temporaneo 253
Motivi di fosforilazione EPIYA nella patogenesi di Helicobacter pylori 232
Antimicrobial and Antibiofilm Efficacy of Graphene Oxide against Chronic Wound Microorganisms 228
Microbial Contamination of Smartphone Touchscreens of Italian University Students 203
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 199
Biological Responses of Human Gingival Fibroblasts (HGFs) in an Innovative Co-Culture Model with Streptococcus mitis to Thermosets Coated with a Silver Polysaccharide Antimicrobial System. 195
Carvacrol codrugs: A new approach in the antimicrobial plan 195
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 193
Studio micriobiologico per il rilievo di Helicobacter pylory nel muco nasale di pazienti dispeptici 192
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 189
Rilievo e ruolo del DNA extracellulare nel biofilm di Helicobacter pylori 188
Effetto del 2-idrossietil-metacrilato (HEMA) sulla co-coltivazione di Streptococcus Mitis e fibroblastigengivali umani 187
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies 187
Transport medium for isolation and identification of Helicobacter pylori. 186
Confronto di patterns di DNA da Helicobacter pylori isolati dal corpo e dall'antro 184
Arginine- and lysine-rich peptides: Synthesis, characterization and antimicrobial activity 184
Adhesion of human gingival fibroblasts/Streptococcus mitis co-culture on the nanocomposite system Chitlac-nAg 184
Antibacterial effect of plant extracts against Helicobacter pylori 184
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 182
NUOVO TERRENO DI TRASPORTO “GESA” PER L’ISOLAMENTO DI HELICOBACTER PYLORI DA BIOPSIE GASTRICHE 180
Isolamento di una proteina, mediante cromatografia di affinità con glutatione, da un ceppo anaerobio di Bacteroides fragilis. 179
Complex Electromagnetic Fields Reduce Candida albicans Planktonic Growth and Its Adhesion to Titanium Surfaces 178
Activity of tea tree oil and nerolidol alone or in combination against Pediculus capitis (head lice) andits eggs 177
Liposome-induced exfoliation of graphite to few-layer graphene dispersion with antibacterial activity 177
Curcumin, an antibiotic resistance breaker against a multiresistant clinical isolate of Mycobacterium abscessus 173
Bacterial response to the exposure of 50 Hz electromagnetic fields. 172
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 171
Biofilms in Chronic Wound Infections: Innovative Antimicrobial Approaches Using the In Vitro Lubbock Chronic Wound Biofilm Model. 170
Cephalosporins are scavengers of hypochlorous acid 167
The antibacterial and antifungal capacity of eight commercially available types of mouthwash against oral microorganisms: an in vitro study 166
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 165
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 165
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 164
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 164
Recupero di Helicobacter pylori ATCC 43504 dallo stato vitale non colturabile (VNC) 163
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 162
The viable but not culturable (VBNC) state in helicobacter pylori 160
New transport medium for cultural recovery of Helicobacter pylori 160
Effetto della deprivazione di 02 sulla morfologia e sulla crescita di Helicobacter pylori 157
Efficacy of carvacrol against resistant rapidly growing mycobacteria in the planktonic and biofilm growth mode 156
Attività in vitro di Tea Tree oil e Nerolidol da soli e in combinazione nei confronti di Pediculus capitis e delle sue lendini 155
Synthesis of Short Cationic Antimicrobial Peptidomimetics Containing Arginine Analogs 154
Bio-Toxicological Assay to Test Water and Sediment Quality. 154
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 153
Trasmissione di Helicobacter pylori in un modello murino 152
Antibacterial and Antibiofilm Properties of Three Resin-Based Dental Composites against Streptococcus mutans 152
A model of Helicobacter pylori persistence in a case of gastric cancer 149
Detection of Helicobacter pylori in saliva and esophagus 149
Helicobacter pylori Dormant States Are Affected by Vitamin C 148
The effect of a silver nanoparticle polysaccharide system on streptococcal and saliva-derived biofilms. 148
In vitro activity of Aloe vera inner gel against microorganism grown in planktonic and sessile phase 148
Preliminary studies on the effect of glutathione S-transferase from Providencia stuartii on the antimicrobial activity of different antibiotics. 147
Questionario di Microbiologia 147
Helicobacter pylori strategies to overcome environmental stress 146
Attività in vitro di farmaci antibatterici verso ceppi di Proteus spp. causanti U.T.I. 146
Effect of Pefloxacin of Proteus-Providencia spp. to squamous epithelial cells. 144
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 144
Valutazione dell'adesività di ceppi del genere Proteus a cellule dell'epitelio urinario. 144
Adhesive properties of Proteus genus related with antimicrobial agents resistance. 143
Caratterizzazione di un isolato marino di Helicobacter pylori 143
Effetto del sistema polisaccaridico di nanoparticelle d’argento (Chitlac-nAg) sui biofilm di Streptococchi orali e saliva 143
Biofilm formation and modulation of luxS and rpoD expression by Helicobacter pylori. 142
Rifabutin based triple therapy for eradication of H.pylori primary and secondary resistant to tinidazole and clarithromycin 141
Helicobacter pylori in fase planctonica e sessile: comportamento in risposta a diversi terreni di coltura 141
Effects of Extremely Low-Frequency Electromagnetic Fields on Helicobacter pylori Biofilm. 141
Recovery of Helicobacter pylori ATCC43504 from a viable but not culturable state: regrowth or resuscitation? 140
In vitro activity of Aloe vera inner gel against microorganisms grown in planktonic and sessile phases 140
Glutathione transferase in bacteria: subunit composition and antigenic characterization. 138
Dynamic colonization of Helicobacter pylori in human gastric mucosa. 138
Antimicrobial Combined Action of Graphene Oxide and Light Emitting Diodes for Chronic Wound Management 138
Purification and characterization of three forms of glutathione transferase from Proteus mirabilis. 137
Antimicrobial peptide l18r displays a modulating action against inter-kingdom biofilms in the lubbock chronic wound biofilm model 137
Extracellular DNA in Helicobacter pylori biofilm: a backstairs rumor 136
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 135
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 133
pPKC α regulates through integrin β 1 human gingival fibroblasts/Streptococcus mitis adhesion in response to HEMA 133
Effetti del 2-idrossi-etil-metacrilato sul Biofilm prodotto da Streptococchi orali 133
Laser irradiation effect on Staphylococcus aureus and Pseudomonas aeruginosa biofilms isolated from venous leg ulcer 132
Detection of Helicobacter pylori in esophagus and saliva in humans 132
Anti-adhesive and pro-apoptotic effects of 2-hydroxyethyl methacrylate on human gingival fibroblasts co-cultured with Streptococcus mitis strains. 132
Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections. 131
Effect of 2-hydroxyethyl methacrylate on Streptococcus spp. biofilms. 131
Bacterial isolates from infected wounds and their antibiotic susceptibility pattern: some remarks about wound infection 131
Monitoraggio microbiologico quantitativo degli ambienti di uno studio odontoiatrico 130
Selezione in vitro delle resistenze a beta-lattamine in recenti stipiti ospedalieri di Enterobacteriaceae e Pseudomonas. 130
Distribuzione degli isoenzimi della glutatione trasferasi in vari ceppi batterici. 130
Enterococcus hirae biofilm formation on hospital material surfaces and effect of new biocides 130
The effect of O2 deprivation on the morphology and growth of Helicobacter pylori 129
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 129
Biofilm microbici come sistema dinamico in risposta allo stress ambientale. Approcci innovativi nella prevenzione e formulazione di nuove strategie terapeutiche integrate 129
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 129
Antimicrobial evaluation of selected naturally occurring oxyprenylated secondary metabolites 129
Caratterizzazione e significato clinico della conversione morfologica di helicobacter pylori 128
The effect of oxygen on the growth and cell morphology of Helicobacter pylori. 128
Detection of Helicobacter pylori associated with zooplankton 128
Temporal expression of agrB, cidA and alsS in the early development of Staphylococcus aureus UAMS-1 biofilm formation and the structural role of extracellular DNA and carbohydrates 128
Hop Extract: An Efficacious Antimicrobial and Anti-biofilm Agent Against Multidrug-Resistant Staphylococci Strains and Cutibacterium acnes 128
Prevalenza della glutatione transferasi nella regione periplasmatica di Proteus mirabilis 127
Totale 15.813
Categoria #
all - tutte 118.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022854 0 0 0 0 85 22 19 87 120 57 129 335
2022/20233.067 285 402 203 299 268 620 203 218 358 59 92 60
2023/20241.420 82 57 85 54 66 468 340 44 13 27 32 152
2024/20254.040 278 769 675 69 66 129 121 181 419 172 415 746
2025/20268.295 602 355 996 1.081 704 478 1.279 562 891 730 431 186
2026/20272.892 264 488 501 1.178 461 0 0 0 0 0 0 0
Totale 30.547